OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prescriber's Guide
Stephen M. Stahl
(2020)
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Depressive Disorders
C Olmos, João Quevedo
Cambridge University Press eBooks (2025), pp. 145-157
Closed Access

Paraphilia and Hypersexuality in Bipolar I Disorder and Histrionic Personality Disorder: A Case Report
Teresa Tavares, Marco A Orsini, Manuela Páfaro Magnani, et al.
Cureus (2025)
Open Access

Patterns in (es)citalopram prescriptions to Medicaid and Medicare patients in the United States: the potential effects of evergreening
Luke R. Cavanah, Parita K. Ray, Jessica L. Goldhirsh, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access

How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice
Stephen M. Stahl, Sireena Sy, Gerald A. Maguire
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 2, pp. 172-180
Closed Access | Times Cited: 29

Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor
Sophie Liabeuf, Vesna Pešić, Goce Spasovski, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 12, pp. 2365-2377
Open Access | Times Cited: 7

Top Ten Tips Palliative Care Clinicians Should Know About the Physical Manifestations of Psychiatric Illness and Treatment
Gregg A. Robbins-Welty, Daniel Shalev, Paul A. Riordan, et al.
Journal of Palliative Medicine (2024) Vol. 27, Iss. 11, pp. 1531-1540
Closed Access | Times Cited: 2

Rise of escitalopram and the fall of citalopram
Luke R. Cavanah, Parita K. Ray, Jessica L. Goldhirsh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Use of the Third-Generation Atypical Antipsychotic Aripiprazole (Zylaxera®) for Treatment of Depressive States in Schizophrenia: Efficacy and Safety Study
И. В. Олейчик, P A Baranov, T. I. Shishkovskaia
Psikhiatriya (2023) Vol. 21, Iss. 3, pp. 6-19
Open Access | Times Cited: 3

Mitigating Pediatric Inpatient Aggression: A Quality Improvement Initiative
Amy R. Keller, Rebecca L. Kanaley, Taylor Starr, et al.
Hospital Pediatrics (2022) Vol. 12, Iss. 5, pp. 499-506
Closed Access | Times Cited: 4

Specialty-type and state-level variation in paroxetine use among older adult patients
Luke R. Cavanah, Jessica L. Goldhirsh, Leighton Y. Huey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Standard of practice in mental health for pharmacy services
Helen Lowy, Viandro Borja, Bailey Stewart, et al.
Journal of Pharmacy Practice and Research (2023) Vol. 53, Iss. 4, pp. 204-225
Closed Access | Times Cited: 2

From Urinary Retention to Increased Urinary Frequency: A Case Report on Mirtazapine\'s Unusual Side Effect
Rachit Sharma, Rishabh Kumar Singh
Indian Journal of Private Psychiatry (2024) Vol. 18, Iss. 1, pp. 35-36
Open Access

Why so down?
Sutanaya Pal
Cambridge University Press eBooks (2024), pp. 199-214
Closed Access

Long-term effects of benzodiazepine discontinuation among older adults: potential improvements on depressive symptoms
Arnaud Allary, Virginie Proulx-Tremblay, Claude Bélanger, et al.
Aging & Mental Health (2024) Vol. 28, Iss. 12, pp. 1625-1633
Open Access

National patterns of paroxetine use among US Medicare patients from 2015–2020
Luke R. Cavanah, Jessica L. Goldhirsh, Leighton Y. Huey, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access

Antidepressants in psychiatric practice
E. Abritalin, I. Yu. Khabarov
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 6, pp. 126-126
Closed Access

Foundations for a Personalized Psycho-Oncology: The State of the Art
Giampaolo Perna, Eleonora Pinto, Alessandro Spiti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 892-892
Open Access

Activity-Related Transcription: Role in Addiction
Jacob S. Rounds, Dina P. Matheos, Marcelo A. Wood
(2024), pp. 379-407
Closed Access

Olanzapine-Induced Withdrawal Oculogyric Crisis in an Adolescent With a Neurodevelopmental Disorder
Kayley Liuzzo, Danielle L. Stutzman, James D. Murphy
The Journal of Pediatric Pharmacology and Therapeutics (2020) Vol. 25, Iss. 5, pp. 455-458
Open Access | Times Cited: 3

A quetiapina: 3 medicamentos em uma única molécula: uma breve revisão e atualização
Leonardo Caixeta, Ciro Vargas, Yanley Lucio Nogueira, et al.
Debates em Psiquiatria (2023) Vol. 13, pp. 1-20
Open Access | Times Cited: 1

The Glutamatergic System as a Target for the Development of New Pharmacological Treatments of Bipolar Disorder
Grigorios N. Karakatsoulis, Konstantinos Ν. Fountoulakis
Springer eBooks (2022), pp. 261-282
Closed Access | Times Cited: 2

Psychopharmacology
Raffaella Zanardi, M. Spangaro, F. Attanasio, et al.
Springer eBooks (2022), pp. 333-388
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top